Logo image
Bacterial enterotoxins are associated with resistance to colon cancer
Journal article   Open access   Peer reviewed

Bacterial enterotoxins are associated with resistance to colon cancer

G M Pitari, L V Zingman, D M Hodgson, A E Alekseev, S Kazerounian, M Bienengraeber, G Hajnóczky, A Terzic and S A Waldman
Proceedings of the National Academy of Sciences - PNAS, Vol.100(5), pp.2695-2699
03/04/2003
DOI: 10.1073/pnas.0434905100
PMCID: PMC151403
PMID: 12594332
url
https://doi.org/10.1073/pnas.0434905100View
Published (Version of record) Open Access

Abstract

One half million patients suffer from colorectal cancer in industrialized nations, yet this disease exhibits a low incidence in under-developed countries. This geographic imbalance suggests an environmental contribution to the resistance of endemic populations to intestinal neoplasia. A common epidemiological characteristic of these colon cancer-spared regions is the prevalence of enterotoxigenic bacteria associated with diarrheal disease. Here, a bacterial heat-stable enterotoxin was demonstrated to suppress colon cancer cell proliferation by a guanylyl cyclase C-mediated signaling cascade. The heat-stable enterotoxin suppressed proliferation by increasing intracellular cGMP, an effect mimicked by the cell-permeant analog 8-br-cGMP. The antiproliferative effects of the enterotoxin and 8-br-cGMP were reversed by L-cis-diltiazem, a cyclic nucleotide-gated channel inhibitor, as well as by removal of extracellular Ca(2+), or chelation of intracellular Ca(2+). In fact, both the enterotoxin and 8-br-cGMP induced an L-cis-diltiazem-sensitive conductance, promoting Ca(2+) influx and inhibition of DNA synthesis in colon cancer cells. Induction of this previously unrecognized antiproliferative signaling pathway by bacterial enterotoxin could contribute to the resistance of endemic populations to intestinal neoplasia, and offers a paradigm for targeted prevention and therapy of primary and metastatic colorectal cancer.
Calcium - metabolism Colonic Neoplasms - prevention & control Humans Colonic Neoplasms - metabolism Dose-Response Relationship, Drug Peptides - metabolism Gastrointestinal Hormones - metabolism Receptors, Peptide Cell Differentiation Tumor Cells, Cultured Colonic Neoplasms - therapy Membrane Potentials - drug effects Signal Transduction Receptors, Cell Surface - metabolism DNA - metabolism Receptors, Enterotoxin Immunity, Innate Cell Division - drug effects Receptors, Guanylate Cyclase-Coupled Natriuretic Peptides Patch-Clamp Techniques Escherichia coli Proteins Guanylate Cyclase Bacterial Toxins - pharmacology Colonic Neoplasms - pathology Ligands Enterotoxins - pharmacology

Details

Metrics

Logo image